Business | Thomson Reuters | Tuesday September 22, 2015
Serum Institute of India, Asia's largest vaccine maker, plans to file for fast-track approval to launch a dengue treatment in India, its chief executive said, potentially becoming the first company globally to launch a drug for the mosquito-borne virus.
www.ndtv.com/business